nominally significantp = 0.036
5c ), though two drug classes are nominally significant before controlling the false discovery rate: proton pump inhibitors (PPIs) ( p = 0.036) and anti-hyperglycemics ( p = 0.041).
5c ), though two drug classes are nominally significant before controlling the false discovery rate: proton pump inhibitors (PPIs) ( p = 0.036) and anti-hyperglycemics ( p = 0.041).